Hagens Berman Sobol Shapiro, Llp
Professional Services |
Law Firms
Cambridge, MA 02142
Recent News About Hagens Berman Sobol Shapiro, Llp
View More
-
PHILADELPHIA (Legal Newsline) - Prominent plaintiffs’ law firm Hagens Berman can’t use the attorney-client privilege to shield information it gave to an outside ethics expert hired to defend the firm against claims it improperly pursued thalidomide claims despite strong evidence they were barred by the statute of limitations.
-
PHILADELPHIA – With the case set to press on after a harsh ruling from the judge hearing it, the law firm Hagens Berman has reached a settlement with a disgruntled former client.
-
PHILADELPHIA (Legal Newsline) - Saying a claimed “emergency” might be more of a delaying tactic, the judge overseeing a lawsuit by a disgruntled former client of the law firm Hagens Berman rejected a request to halt the proceedings while the firm appeals his ruling denying a venue change out of his court.“The sky has not fallen,” wrote U.S.
-
A special master investigating how the prominent class action firm Hagens Berman handled failed lawsuits over the banned morning sickness drug thalidomide has chastised the firm in unusually strong terms for redacting the entire report it commissioned from an ethics expert, down to the letterhead and page numbers.
-
PHILADELPHIA (Legal Newsline) - A long-simmering fight between the prominent plaintiffs’ law firm Hagens Berman Sobol Shapiro and several unhappy clients has escalated into open war as one of them sued her former lawyers for allegedly misleading her about the chances of winning a lawsuit based on decades-old claims of being exposed to the dangerous morning-sickness drug thalidomide.
-
WASHINGTON (Legal Newsline) - Class action lawyers who see arbitration as a mortal threat to their business have found unlikely allies among some of the nation’s most conservative state officials.
-
It was a surprising opening move, to say the least. Arguing for the City of New York in its climate lawsuit against five major oil companies, attorney Michael Pawa cited AEP v. Connecticut, a 2009 decision by the U.S. Court of Appeals for the Second Circuit, as “persuasive authority” in his clients’ favor.
-
PHILADELPHIA – A federal judge in Philadelphia recently denied an attempt on the part of pharmaceutical giant GlaxoSmithKline to reallocate costs and fees incurred through still-pending investigative discovery, to the plaintiffs’ counsel in a thalidomide products injury action.
